AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Potential breakthrough in obesity treatment and beyond
Semaglutide has shown potential in reducing preserved ejection heart failure, preventing heart attacks, strokes, and cardiovascular deaths. While the drug is currently injectable and expensive, trials indicate the possibility of pill forms becoming available, with costs expected to decrease. This breakthrough in obesity treatment may extend to benefit liver disease, kidney diseases, heart conditions, and possibly Alzheimer's. The drug could potentially serve as a remedy for various chronic diseases if it becomes more affordable and does not require frequent injections. The ongoing trials and possibilities for semaglutide are seen as extraordinary, although it is still in its early stages of development.